This week on Contemporary OB/GYN®: Jan. 31 to Feb. 4
A look at what's coming to Contemporary OB/GYN® this week.
Glenmark Pharmaceuticals gets FDA approval for generic MetroGel
The drug is used to treat bacterial vaginosis and is a generic version of Bausch Health US LLC’s MetroGel-Vaginal.
Balancing the rewards and risks of hormonal acne treatments
Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.
American Heart Month
February is American Heart Month. Each week, explore the facts, statistics, and resources available for women's heart health.
Coming soon
Statin use in midlife women
Risk assessment, lifestyle counseling, adverse effects, and medication management.
Coming soon
February 4: World Cancer Day
Friday marks World Cancer Day, an international awareness campaign led by the Union for International Cancer Control (IUCC). This year's theme is #CloseTheCareGap. Check back for toolkits, infographics, posters and more.
Coming soon
SMFM 2022 Annual Meeting
This week marks the beginning of the Society for Maternal-Fetal Medicine's 2022 Annual Meeting. Join us for the best of this year's virtual presentations, panel discussions, roundtables, and more.
Coming soon
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More
